| Batch Notification Number |
BN-OL-2022-09-27-4940
|
| FDA Registered Product/Generic Name |
Neomycin + Gramicidin + Nystatin + Triamcinolone Acetonide
|
| Brand Name |
OTICOM
|
| Dosage Strength |
2.5 mg/ 0.25 mg/ 100,000 units/ 1 mg per mL
|
| Dosage Form |
Solution Otic
|
| Registration Number |
DRP-2370
|
| Batch Number |
N/A
|
| Lot Number |
2B17D
|
| Product Expiration Date |
1 September 2024
|
| Issuance Date |
27 September 2022
|